Norman Sharpless

Mar 12, 2019

The US Health and Human Services Secretary Alex Azar has appointed Norman Sharpless as acting commissioner of the US Food and Drug Administration. Sharpless, currently the director of the National Cancer Institute, will take over for current FDA Commissioner Scott Gottlieb who announced on March 5 that he will resign from the post in one month. Before his position at the NCI, Sharpless directed the University of North Carolina's Lineberger Comprehensive Cancer Center, authored more than 100 research papers, and treated leukemia patients.

Norman Sharpless

Vanderbilt Team Reports on Clinical Genetic Testing Patterns Over Two Decades

BioMérieux Confirms Full-Year Growth Guidance as Q1 Sales Rise 14 Percent

Sonrai, Paige Partner to Build AI Interface for Biopharma Researchers and Clinicians

NIH Funding Cut by 40 Percent in Trump Admin's FY2026 Budget Proposal

Illumina Lays off More Than 300 Employees